← Back to Search

Behavioral Intervention

PRISM Program for Depression and Anxiety (PRISM Trial)

N/A
Waitlist Available
Led By Samantha Bento, PhD
Research Sponsored by Dana-Farber Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* 18-25 years of age
* Speak and comprehend English sufficiently to be able to complete study procedures and participate in the program in English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 weeks
Awards & highlights

Summary

This research study is being done to test the feasibility of an existing supportive program (PRISM) to address psychological symptoms (i.e., depressive and anxiety symptoms) that young adult participants diagnosed with cancer may experience. The name of the intervention used in this research study is: -Promoting Resilience in Stress Management (PRISM) Program

Who is the study for?
This trial is for young adults with cancer who are experiencing symptoms of depression and anxiety. The study aims to see if a program called PRISM can help manage these psychological symptoms.
What is being tested?
The intervention being tested is the Promoting Resilience in Stress Management (PRISM) Program, which is designed to support young adults with cancer by addressing their depressive and anxiety symptoms.
What are the potential side effects?
Since PRISM is a supportive program focusing on stress management, it does not involve medication or medical procedures; therefore, traditional physical side effects are not expected.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Participant Satisfaction
Rate of PRISM Intervention Completion
Rate of Study Assessment Completion
Secondary study objectives
Questionnaires
mPRISM Phone Application Usage

Trial Design

1Treatment groups
Experimental Treatment
Group I: PRISM ProgramExperimental Treatment1 Intervention
Participants will be enrolled and will complete study procedures as follows: * Baseline visit with questionnaires. * 6 weekly or bi-weekly remote or in-clinic, psychotherapy sessions with psychologist. * Final questionnaires and post-study exit interview

Find a Location

Who is running the clinical trial?

Dana-Farber Cancer InstituteLead Sponsor
1,098 Previous Clinical Trials
345,027 Total Patients Enrolled
Samantha Bento, PhDPrincipal InvestigatorDana-Farber Cancer Institute
Greta Jankauskaite, PhDStudy DirectorDana-Farber Cancer Institute
~10 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top